Literature DB >> 11313470

Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation.

B Xu1, M B Kastan.   

Abstract

Cell cycle arrests in the G(1), S, and G(2) phases occur in mammalian cells after ionizing irradiation and appear to protect cells from permanent genetic damage and transformation. Though Brca1 clearly participates in cellular responses to ionizing radiation (IR), conflicting conclusions have been drawn about whether Brca1 plays a direct role in cell cycle checkpoints. Normal Nbs1 function is required for the IR-induced S-phase checkpoint, but whether Nbs1 has a definitive role in the G(2)/M checkpoint has not been established. Here we show that Atm and Brca1 are required for both the S-phase and G(2) arrests induced by ionizing irradiation while Nbs1 is required only for the S-phase arrest. We also found that mutation of serine 1423 in Brca1, a target for phosphorylation by Atm, abolished the ability of Brca1 to mediate the G(2)/M checkpoint but did not affect its S-phase function. These results clarify the checkpoint roles for each of these three gene products, demonstrate that control of cell cycle arrests must now be included among the important functions of Brca1 in cellular responses to DNA damage, and suggest that Atm phosphorylation of Brca1 is required for the G(2)/M checkpoint.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313470      PMCID: PMC100266          DOI: 10.1128/MCB.21.10.3445-3450.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  28 in total

1.  Defect in multiple cell cycle checkpoints in ataxia-telangiectasia postirradiation.

Authors:  H Beamish; R Williams; P Chen; M F Lavin
Journal:  J Biol Chem       Date:  1996-08-23       Impact factor: 5.157

Review 2.  Cell cycle checkpoints: preventing an identity crisis.

Authors:  S J Elledge
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

3.  Fragments of ATM which have dominant-negative or complementing activity.

Authors:  S E Morgan; C Lovly; T K Pandita; Y Shiloh; M B Kastan
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

Review 4.  The genetic defect in ataxia-telangiectasia.

Authors:  M F Lavin; Y Shiloh
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

Review 5.  Cell cycle control and cancer.

Authors:  L H Hartwell; M B Kastan
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

6.  Radiosensitivity in ataxia-telangiectasia: a new explanation.

Authors:  R B Painter; B R Young
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

7.  Recombinant ATM protein complements the cellular A-T phenotype.

Authors:  Y Ziv; A Bar-Shira; I Pecker; P Russell; T J Jorgensen; I Tsarfati; Y Shiloh
Journal:  Oncogene       Date:  1997-07-10       Impact factor: 9.867

Review 8.  p53 and ATM: cell cycle, cell death, and cancer.

Authors:  S E Morgan; M B Kastan
Journal:  Adv Cancer Res       Date:  1997       Impact factor: 6.242

9.  Cell death, chromosome damage and mitotic delay in normal human, ataxia telangiectasia and retinoblastoma fibroblasts after x-irradiation.

Authors:  F Zampetti-Bosseler; D Scott
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1981-05

10.  The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia.

Authors:  C E Canman; A C Wolff; C Y Chen; A J Fornace; M B Kastan
Journal:  Cancer Res       Date:  1994-10-01       Impact factor: 12.701

View more
  178 in total

1.  Brca2 (XRCC11) deficiency results in radioresistant DNA synthesis and a higher frequency of spontaneous deletions.

Authors:  Maria Kraakman-van der Zwet; Wilhelmina J I Overkamp; Rebecca E E van Lange; Jeroen Essers; Annemarie van Duijn-Goedhart; Ingrid Wiggers; Srividya Swaminathan; Paul P W van Buul; Abdellatif Errami; Raoul T L Tan; Nicolaas G J Jaspers; Shyam K Sharan; Roland Kanaar; Malgorzata Z Zdzienicka
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

2.  SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint.

Authors:  Parvin T Yazdi; Yi Wang; Song Zhao; Nimitt Patel; Eva Y-H P Lee; Jun Qin
Journal:  Genes Dev       Date:  2002-03-01       Impact factor: 11.361

3.  Involvement of the cohesin protein, Smc1, in Atm-dependent and independent responses to DNA damage.

Authors:  Seong-Tae Kim; Bo Xu; Michael B Kastan
Journal:  Genes Dev       Date:  2002-03-01       Impact factor: 11.361

4.  Distinct roles of FANCO/RAD51C protein in DNA damage signaling and repair: implications for Fanconi anemia and breast cancer susceptibility.

Authors:  Kumar Somyajit; Shreelakshmi Subramanya; Ganesh Nagaraju
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

5.  A subset of ATM- and ATR-dependent phosphorylation events requires the BRCA1 protein.

Authors:  Nicolas Foray; Didier Marot; Anastasia Gabriel; Voahangy Randrianarison; Antony M Carr; Michel Perricaudet; Alan Ashworth; Penny Jeggo
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

6.  Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription.

Authors:  Hiroyuki Takai; Kazuhito Naka; Yuki Okada; Miho Watanabe; Naoki Harada; Shin'ichi Saito; Carl W Anderson; Ettore Appella; Makoto Nakanishi; Hiroshi Suzuki; Kazuo Nagashima; Hirofumi Sawa; Kyoji Ikeda; Noboru Motoyama
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

Review 7.  Emerging roles of BRCA1 alternative splicing.

Authors:  T I Orban; E Olah
Journal:  Mol Pathol       Date:  2003-08

8.  Next-generation sequencing of BRCA1 and BRCA2 in breast cancer patients and control subjects.

Authors:  Lubomir Balabanski; Georgi Antov; Ivanka Dimova; Samuil Ivanov; Maria Nacheva; Ivan Gavrilov; Desislava Nesheva; Blaga Rukova; Savina Hadjidekova; Maxim Malinov; Draga Toncheva
Journal:  Mol Clin Oncol       Date:  2014-02-04

9.  Uterus hyperplasia and increased carcinogen-induced tumorigenesis in mice carrying a targeted mutation of the Chk2 phosphorylation site in Brca1.

Authors:  Sang Soo Kim; Liu Cao; Cuiling Li; Xiaoling Xu; L Julie Huber; Lewis A Chodosh; Chu-Xia Deng
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

10.  Cyclin E2 induces genomic instability by mechanisms distinct from cyclin E1.

Authors:  C Elizabeth Caldon; C Marcelo Sergio; Andrew Burgess; Andrew J Deans; Robert L Sutherland; Elizabeth A Musgrove
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.